Furthermore, there was significant reduced cytoplasmic and nuclear p-Pak2 expression in endometrial cancers than that in complex hyperplasia (P = 0.009 and P = 0.006, respectively) and pure atypical hyperplasia (P = 0.038 and P = 0.042, respectively) (Fig 2B). The gene discussed is PAK2; the disease is endometrial cancer.